Latest news with #Knowledge
The Courier
24-05-2025
- Entertainment
- The Courier
'Other Murray brother' Duncan's 5 favourite places in Dunblane
Duncan Murray has lived in Dunblane all his life and knows his hometown like the back of his hand. No gallivanting across the globe (say to France, Australia or Wimbledon) for Duncan. He's Dunblane through and through. He's also fictional – the unfortunate 'other Murray brother' who couldn't play tennis, made up by Scottish comedian Chris Forbes. Judy Murray, mother of Sir Andy and Jamie, got in on the joke in 2019, and the result was so convincing, lots of people still don't realise it's a joke. 'Duncan' has gone on to perform live with Judy and become beloved in his own right. He may be a character but he's larger than life, so we at The Courier asked him to choose his five favourite places in Dunblane and tell us why he loves them. Duncan's first tip is to visit a certain postbox in Dunblane town centre. 'Just to be clear – no, I don't mean my brother's gold postbox on the High Street,' he says. 'To be honest I think the colour of that one makes it look a bit tacky. 'Andy's box gets enough attention as it is. I feel bad for the overlooked classic red wall box, which is just as valuable and just as useful as its golden counterpart. 'Sure, no one wants their photo with the older box, and it might not be as exciting. But I think we are both worthy of love. 'The postboxes are both worthy, I mean. I'm definitely just talking about postboxes.' A well-known lover of the arts and performing, Duncan has a special place in his heart for Rubber Chicken Theatre on the High Street. He calls it 'one of the most culturally and artistically important performing arts centres, not just in Dunblane, but in the whole world.' Duncan explains: 'Mum and I rehearsed here for our live shows. 'I think, in time, people from all around the globe will travel here like a pilgrimage, in the same way people visit Abbey Road or the Globe theatre, keen to get a glimpse of where such an iconic duo like me and Mum once graced the humble floorboards.' Yards away from Dunblane Sports Club, where Andy and Jamie first played tennis, Duncan forged his own legacy – at the Scout hall. 'I always loved my time here, even though being a Cub was much more challenging than I expected,' he admits. 'Some of the badges were practically impossible to earn. 'I managed to get my Home Help, Hobbies, and Collector badges, but I'm actually still trying to earn my Athletics, Community Impact, and Local Knowledge awards. 'Maybe this article will help me with that last one. 'Technically, as I'm still active in my quest for badges, I am the longest serving Cub in Dunblane history.' The lush, green Ochlochy Park is a hidden gem, particularly on a sunny day. 'I spent a lot of time in this park as a kid,' says Duncan. 'Mostly because my mum would drop me off here on her way to the tennis centre with Andy and Jamie. 'At first, they would bring me along to act as a ball boy. But once it became clear that I had no talent at catching, throwing, or even holding the balls (they're all fuzzy and feel funny), Ochlochy Park became my daily hangout. 'I loved wandering aimlessly, feeding the ducks, and chasing squirrels. 'I'd play my own games, like hide-and-seek and tig. Admittedly, harder to play by yourself, but at least no one was yelling about double faults and forearm smashes.' If you're a local, you've probably spotted Duncan in his final favourite Dunblane spot before. And if you're an M&S staff member, you've probably tactfully tried to get him to leave a few times. 'Sometimes I spend hours and hours in here and I don't even like tea or coffee,' he reveals. 'But if I wait in here long enough, sometimes I get lucky and see my mum pop in for her shopping, and then I can plead with her to come and join me for a catch-up. 'She often refuses at first, but eventually I wear her down with the promise of cake.'
Business Wire
22-05-2025
- Business
- Business Wire
Flatiron Health Announces Research to Be Presented at ASCO 2025
NEW YORK--(BUSINESS WIRE)--Flatiron Health today announced 14 abstracts leveraging its high-quality real-world oncology data have been accepted for poster presentation and online publication at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. These studies exemplify Flatiron's commitment to advancing cancer research and align with this year's ASCO theme, 'Driving Knowledge to Action: Building a Better Future,' by delivering critical evidence to inform and improve patient care. Our research accepted at this year's ASCO demonstrates our lasting commitment to deliver actionable evidence and improve care for every person with cancer. Share 'AI and related technologies have enabled us to unlock data and insights from our entire network of over five million people with cancer, providing unprecedented scale, efficiency, and innovation for both real-world evidence generation and clinical trial execution,' said Stephanie Reisinger, Senior Vice President & General Manager, Real-World Evidence. 'Our research accepted at this year's ASCO demonstrates our lasting commitment to deliver actionable evidence and improve care for every person with cancer.' Highlights include: a poster presentation utilizing advanced machine learning models to identify a cohort of over 195,000 to complete the largest real-world study to date examining ctDNA testing in early stage breast cancer an abstract assessing how often PSMA-PET scans were used among non-Latinx/Hispanic White, Black, and Latinx patients with metastatic prostate cancer an abstract demonstrating the potential of a centralized, tech-enabled screening service to make clinical trial enrollment and more efficient, particularly in community oncology settings Schedule a meeting with Flatiron Health at ASCO 2025, and learn more about our abstracts and events, including workshops and panels. Follow Flatiron Health on X and LinkedIn for more updates from #ASCO25 and visit us in person at Booth #11131. Partners: University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado School of Public Health Erin Fidyk, Patrick Ward, Melissa Estevez, Konstantin Krismer, John Ritten, Anca Marinescu, Aaron B. Cohen Breast Cancer—Local/Regional/Adjuvant Poster board: 148 Abstract number: 555 Partners: Memorial Sloan Kettering Cancer Center, AstraZeneca Dana Rathkopf, Danni Zhao, Lana Kovacevic, Jenna Collins, Eunice Hankinson, Helen Marshall, Aaron Springford, Simran Shokar, Helene von Bandemer, Weiyan Li Genitourinary—Prostate, Testicular, and Penile Poster board: 295 Abstract number: 5096 Impact of social determinants of health on mortality in diffuse large B-cell lymphoma (DLBCL) using real-world data Partners: Yale School of Medicine, University of Alabama at Birmingham, Fox Chase Cancer Center, University of Texas Southwestern Medical Center, University of Colorado at Anschutz Maureen Canavan, Mengru Wang, Olive Mbah, Maneet Kaur, Michael J. Hall, Adeel Khan, Jessica McDermott, Madeline Schmitter, Anosheh Afghahi, Gaurav Goyal Quality Care/Health Services Research Poster board: 436 Abstract number: 11097 Partners: UCLA, AstraZeneca, Memorial Sloan Kettering Cancer Center, The University of Chicago Jay Lee, Daniel Simmons, Tiernan Mulrooney, Jeremy Snider, Lana Natalija Kovacevic, Karen Schwed, Aditya Juloori Lung Cancer—Non–Small Cell Local-Regional/Small Cell/Other Thoracic Cancers Poster board: 199 Abstract number: 8078 Molecular residual disease (MRD) in solid tumors Partners: Taylor Cancer Research Center, Exact Sciences, Case Comprehensive Cancer Center Majd T. Ghanim, John Nemunaitis, Tara Marti, Abhishek Dabral, Katherine Diaz-MacInnis, Judith Frederick, Marla Kuleszynski, Yichen Lu, Amanda Rodriguez-Sullivan, Melanie Palomares, Natalie Salituro, Soma Subramaniam, Anthony Tate, Kathleen Turnbull, Neal J. Meropol Therapeutics—Molecularly Targeted Agents and Tumor Biology Poster board: 486b Abstract number: TPS3186 Assessment of racial/ethnic inequities in uptake of Prostate Specific Membrane Antigen - Positron Emission Tomography (PSMA-PET) scans among patients with metastatic prostate cancer in the United States (US) Eunice A. Ochuonyo, Samantha Reiss, Patrick J. Ward, Brooke A. Jarrett, Olive Mbah, Prakirthi Yerram, Laura Rivera-Reyes, Sophia Miller, Kelly Magee, Lynn Rosario, Wendy Wittman, Cleo A. Ryals Online publication only Accrual of racially and ethnically underrepresented populations with multiple myeloma associated with centralized patient screening in a multicenter study Partners: University of Colorado, Johnson & Johnson, New York Cancer and Blood Specialists Anosheh Afghahi, Daniel Sanchez, Yichen Lu, Richard M. Zuniga, Laura Heste, Dina Gifkins, Britney Beaulieu, Catharine Cipolla, Barry Leybovich, Debra Mitchell, Jeffrey Nan, Ebube Onwasigwe, Hemang Patel, Paul Salcuni, Chloe Salzman, Neal J. Meropol, Ashita S. Batavia Online publication only A retrospective real-world study of first-line PD-(L)1 inhibitor use in patients with metastatic non-small cell lung cancer (mNSCLC) Partner: Incyte Kim Saverno, Siobhan Halloran, Mark Guinter, Kelly Magee, Michael Ondovik, J.E. Hamer-Maansson, Mark Cornfeld, Mihaela Munteanu Online publication only A retrospective cohort study of real-world clinical outcomes in patients with CLL/SLL previously treated with covalent BTK inhibitor (cBTKi) and BCL2 inhibitor (BCL2i) regimens Partners: Merck & Co, MSD UK, Mayo Clinic Jennifer Prescott, Christina Parrinello, Ahmed Sawas, Enrico De Nigris, Jing Yang, Erik Bloomquist, Indu Shrivastava, Changxia Shao, Xinyue Liu, Mohammed Farooqui, Sameer A. Parikh Online publication only Management and outcomes of rash, peripheral neuropathy (PN), and hyperglycemia (HG) during first-line (1L) treatment (Tx) of locally advanced/metastatic urothelial cancer (la/mUC) in a real-world setting Partners: Cleveland Clinic, Merck KGaA, EMD Serono Amanda Nizam, Mairead Kearney, Valerie Morris, Seyed Hamidreza Mahmoudpour, Carroline Lobo, Chiemeka Ike, Jason Hoffman, Ilian Iliev, Prakirthi Yerram, Mark Guinter Online publication only Concordance of response-based clinical trial and machine learning–generated real-world end points Partner: Genentech Qianyi Zhang, Konstantin Krismer, Yichen Lu, Qianyu Yuan, Aaron Dolor, Auriane Blarre, Aaron B. Cohen, Tori Williams, Sophia Maund, Minu K. Srivastava, Kelly Magee Online publication only Partners: Pfizer, University of San Francisco Helen Diller Family Comprehensive Cancer Center, MD Anderson Cancer Center, Dana-Farber Cancer Institute, European Institute of Oncology IRCCS, University of Milano, UPMC Hillman Cancer Center Hope S. Rugo, Rachel M. Layman, Filipa Lynce, Xianchen Liu, Benjamin Li, Lynn McRoy, Aaron B. Cohen, Melissa Estevez, Giuseppe Curigliano, Adam Brufsky Online publication only Unmet need in adults and adolescents and young adults (AYAs) with B-cell acute lymphoblastic leukemia (B-ALL) in the US following a second relapse Partners: Memorial Sloan Kettering Cancer Center, Stanford Cancer Center, AstraZeneca, Tampa General Hospital Cancer Institute, Knight Cancer Institute, MD Anderson Cancer Center Mark B. Geyer, Michaela Liedtke, Vikram Shetty, Anthony Proli, Yazan K Barqawi, Jenna Collins, Nikesh N. Shah, Jessica T. Leonard, Joseph Elias Jabbour Online publication only About Flatiron Flatiron Health is a healthtech company expanding the possibilities for point of care solutions in oncology and using data for good to power smarter care for every person with cancer. Through machine learning and AI, real-world evidence, and breakthroughs in clinical trials, we continue to transform patients' real-life experiences into knowledge and create a more modern, connected oncology ecosystem. Flatiron Health is an independent affiliate of the Roche Group.
Yahoo
14-05-2025
- Business
- Yahoo
Major Coca-Cola partner makes bold tech shift that could change beverage production forever: 'We are honored'
A Coca-Cola bottler in a demanding market will optimize its supply chain with AI-powered tech, which could ensure better product availability for consumers and lower business costs. As Supply Chain Digital detailed, Coca-Cola Bottlers Japan, Inc., has enlisted the help of o9 Solutions to streamline its day-to-day operations. In order to accomplish this, CCBJI will use o9's Digital Brain platform, whose patented Enterprise Knowledge Graph — powered by artificial intelligence and machine learning — can assist companies with risk assessment and decision-making with its up-to-date, streamlined raw data. CCBJI handles roughly 90% of Coca-Cola system products sold in Japan, which Supply Chain Digital describes as "one of the most complex supply chain environments in Asia." In addition to dealing with geographic diversity and volatility, CCBJI must adhere to strict expiration requirements — the proper management of which prevents unnecessary waste. According to the report, CCBJI anticipates the use of Digital Brain will lead to lower storage costs, more accurate delivery windows, and fewer logistical bottlenecks. It also believes the Dallas-based company's "mathematical optimization" will improve the efficiency of its supply routes. This, in turn, may reduce harmful pollution associated with transport. While Coca-Cola has incorporated electric semis into its delivery fleet in various markets, it still has dirty fuel-guzzling vehicles on the roads, including in Japan. However, the project may not be without its pitfalls. For one, powering AI requires massive amounts of energy, which can stress electrical grids and generate large volumes of pollution. While o9 increased its clean energy consumption in 2023 and says it is committed to further slashing carbon pollution, only 31% of its power came from renewable sources. With further progress, though, CCBJI's use of o9's AI-powered tech may be a sustainability win for Coca-Cola, which has come under scrutiny for quietly backing out of promises to reduce plastic use. The company remains one of the world's top plastic polluters, though it has phased out some plastic packaging components at select facilities. Should everyone have access to free curbside recycling? Yes No I already thought we did I'm not sure Click your choice to see results and speak your mind. "We are honored to support Coca-Cola Bottlers Japan in their efforts to transform their supply planning," o9 co-founder and CEO Chakri Gottemukkala said. "By leveraging our platform to streamline planning processes and optimize supply planning, we will strongly support Coca-Cola Bottlers Japan's transformation." Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet.
Straits Times
03-05-2025
- Politics
- Straits Times
Russia's Medvedev says nobody can guarantee Kyiv's safety if Ukraine attacks Moscow on May 9
Deputy head of Russia's Security Council Dmitry Medvedev delivers a speech during a session of the educational marathon \"Knowledge. First\" in Moscow, Russia, April 29, 2025. Sputnik/Yekaterina Shtukina/Pool via REUTERS Russia's Medvedev says nobody can guarantee Kyiv's safety if Ukraine attacks Moscow on May 9 MOSCOW - Dmitry Medvedev, deputy chairman of Russia's Security Council, said on Saturday that nobody could guarantee that the Ukrainian capital of Kyiv would survive to see May 10 if Ukraine attacked Moscow during World War Two victory celebrations on May 9. Russian President Vladimir Putin on Monday declared a three-day ceasefire in May in the war with Ukraine to mark the 80th anniversary of the victory of the Soviet Union and its allies in World War Two. The Kremlin said the 72-hour ceasefire would run on May 8, May 9 - when Putin will host international leaders including Chinese President Xi Jinping for celebrations to commemorate victory over Nazi Germany - and May 10. Responding to Moscow's offer of the three-day ceasefire, Ukrainian President Volodymyr Zelenskiy said he was ready as long as the ceasefire would be 30 days in length, something Putin had already ruled out in the near term, saying he wants a long-term settlement not a brief pause. Zelenskiy said Ukraine, given the continued war with Russia, could not guarantee the safety of any foreign dignitaries who came to Moscow for the traditional May 9 victory parade. "We cannot be responsible for what happens on the territory of the Russian Federation. They are responsible for your security, and therefore we will not give you any guarantees," he said. Medvedev, a former Russian president who has emerged as one of Moscow's most outspoken anti-Western hawks since the start of Russia's war in Ukraine, called Zelenskiy's statement a "verbal provocation" and said nobody had asked for Kyiv's security guarantees for the May 9 events. "(Zelenskiy) understands that in the event of a real provocation on Victory Day, nobody will be able to guarantee that Kyiv will live to see May 10," Medvedev said on his official Telegram channel. REUTERS Join ST's Telegram channel and get the latest breaking news delivered to you.
Globe and Mail
02-05-2025
- Business
- Globe and Mail
SurgeGraph Announces Beta Launch of New Feature: Knowledge
SurgeGraph has launched Knowledge in beta - an AI feature that lets users upload proprietary information to generate more personalized, unique content. Kuala Lumpur, Malaysia--(Newsfile Corp. - May 2, 2025) - SurgeGraph, the leading AI writing tool, today announced the beta launch of its new feature, "Knowledge". This intelligent tool allows users to upload and leverage proprietary information, enabling the AI within SurgeGraph Vertex to generate more personalized, unique, and information-rich content. Cannot view this video? Visit: Knowledge allows users to build custom libraries by uploading website URLs, text snippets, or documents (PDF, MD, TXT formats up to 5MB). This enables the AI to draw upon knowledge not publicly available, resulting in content that reflects the user's specific expertise and insights. SurgeGraph Announces Beta Launch of New Feature: Knowledge To view an enhanced version of this graphic, please visit: Users can create multiple libraries for different clients or subject areas, with each library supporting up to 30 assets and each asset accommodating up to 40,000 words. The feature also includes a query functionality within each library, allowing users to quickly retrieve specific information via a chatbot interface. During the content writing process, users can designate specific knowledge libraries to inform the AI when building outlines and generating content. The "Knowledge Highlights" feature allows users to quickly spot the portions of the generated text that were sourced from their uploaded materials. "Knowledge directly addresses the challenge of AI-generated text often lacking unique, proprietary, in-house expertise," said Sara Salim, spokesperson for SurgeGraph. "By enabling users to integrate their own unique knowledge directly into the AI workflow, they can produce content that truly differentiates itself and provides significant value to their audience." SurgeGraph will be gathering user feedback during the beta period to further refine and enhance the Knowledge feature. The company has also announced upcoming updates to Knowledge which will include the ability to generate outlines and extract keywords directly from uploaded documents. Those interested in getting beta access to Knowledge can sign up for a SurgeGraph plan at About the company: SurgeGraph is an AI writing tool designed to help agencies and teams generate humanized and unique content at scale. With intelligent AI and SEO features, SurgeGraph helps create SEO-optimized content that ranks high and drives traffic.
